Skip to content

Establishment of Hong Kong Diabesity Register

Establishment of Hong Kong Diabesity Register

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07247409
Enrollment
800
Registered
2025-11-25
Start date
2025-10-22
Completion date
2029-12-31
Last updated
2025-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabesity

Brief summary

All participants of the Diabesity Register will receive structured assessment by nurses guided by the JADE portal at baseline including eye, feet, blood and urine examination with evaluation of BMI, blood pressure, HbA1c, lipid profile, renal and liver function tests, urine for albumin-creatinine ratio. All patients will return at 3-year for a repeat assessment of physical and psychological health, as well as changes over time.

Interventions

OTHERNo Intervention: Observational Cohort

It is an registry so no intervention will be used.

Sponsors

Chinese University of Hong Kong
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

1. Type 2 diabetes; 2. Obesity reaching action level as defined as body mass index (BMI) 27.5 kg/m2 and/or waist circumference (WC) 80cm in women and 90cm in men; 3. Age between 18 and 50 years; 4. Able to conversate with smartphone technology and web-based program. 5. Able to read Chinese and communicate using Chinese.

Exclusion criteria

1. Type 1 diabetes; 2. Active malignant disease including those with history of malignant disease less than 5 years of disease-free duration; 3. Life expectancy less than 12 months; 4. Any medical illness or condition as judged by the investigators as ineligible to participate the study.

Design outcomes

Primary

MeasureTime frameDescription
A composite of incidence3 yearsIncidence of diabetes-related complications

Secondary

MeasureTime frame
Incidence of diabetic mellitus nephropathy3 years
Incidence of diabetic mellitus neuropathy3 years
Incidence of diabetic mellitus retinopathy3 years
Incidence of stroke3 years
Incidence of peripheral artery disease3 years
Incidence of myocardial infarction3 years

Countries

Hong Kong

Contacts

Primary ContactAlice Pik Shan Kong, MD
alicekong@cuhk.edu.hk+852 3505 2648

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026